Counter CM - Search Results

1

Wnt signaling suppresses MAPK-driven proliferation of intestinal stem cells.

Kabiri Z, Greicius G, Zaribafzadeh H, Hemmerich A, Counter CM, Virshup DM. Kabiri Z, et al. Among authors: counter cm. J Clin Invest. 2018 Aug 31;128(9):3806-3812. doi: 10.1172/JCI99325. Epub 2018 Jul 30. J Clin Invest. 2018. PMID: 30059017 Free PMC article.

2

Characterization of the repeat-tract instability and mutator phenotypes conferred by a Tn3 insertion in RFC1, the large subunit of the yeast clamp loader.

Xie Y, Counter C, Alani E. Xie Y, et al. Genetics. 1999 Feb;151(2):499-509. doi: 10.1093/genetics/151.2.499. Genetics. 1999. PMID: 9927446 Free PMC article.

3

Exploiting codon usage identifies intensity-specific modifiers of Ras/MAPK signaling in vivo.

Sawyer JK, Kabiri Z, Montague RA, Allen SR, Stewart R, Paramore SV, Cohen E, Zaribafzadeh H, Counter CM, Fox DT. Sawyer JK, et al. Among authors: counter cm. PLoS Genet. 2020 Dec 9;16(12):e1009228. doi: 10.1371/journal.pgen.1009228. eCollection 2020 Dec. PLoS Genet. 2020. PMID: 33296356 Free PMC article.

4

A novel role for copper in Ras/mitogen-activated protein kinase signaling.

Turski ML, Brady DC, Kim HJ, Kim BE, Nose Y, Counter CM, Winge DR, Thiele DJ. Turski ML, et al. Among authors: counter cm. Mol Cell Biol. 2012 Apr;32(7):1284-95. doi: 10.1128/MCB.05722-11. Epub 2012 Jan 30. Mol Cell Biol. 2012. PMID: 22290441 Free PMC article.

5

Copper is required for oncogenic BRAF signalling and tumorigenesis.

Brady DC, Crowe MS, Turski ML, Hobbs GA, Yao X, Chaikuad A, Knapp S, Xiao K, Campbell SL, Thiele DJ, Counter CM. Brady DC, et al. Among authors: counter cm. Nature. 2014 May 22;509(7501):492-6. doi: 10.1038/nature13180. Epub 2014 Apr 9. Nature. 2014. PMID: 24717435 Free PMC article.

6

Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth.

Kashatus JA, Nascimento A, Myers LJ, Sher A, Byrne FL, Hoehn KL, Counter CM, Kashatus DF. Kashatus JA, et al. Among authors: counter cm. Mol Cell. 2015 Feb 5;57(3):537-51. doi: 10.1016/j.molcel.2015.01.002. Mol Cell. 2015. PMID: 25658205 Free PMC article.

7

Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer.

Weyandt JD, Lampson BL, Tang S, Mastrodomenico M, Cardona DM, Counter CM. Weyandt JD, et al. Among authors: counter cm. PLoS One. 2015 Oct 9;10(10):e0140253. doi: 10.1371/journal.pone.0140253. eCollection 2015. PLoS One. 2015. PMID: 26452271 Free PMC article.

8

Copper Chelation Inhibits BRAF^V600E-Driven Melanomagenesis and Counters Resistance to BRAF^V600E and MEK1/2 Inhibitors.

Brady DC, Crowe MS, Greenberg DN, Counter CM. Brady DC, et al. Among authors: counter cm. Cancer Res. 2017 Nov 15;77(22):6240-6252. doi: 10.1158/0008-5472.CAN-16-1190. Epub 2017 Oct 6. Cancer Res. 2017. PMID: 28986383 Free PMC article.

9

Wild-type Kras expands and exhausts hematopoietic stem cells.

Sasine JP, Himburg HA, Termini CM, Roos M, Tran E, Zhao L, Kan J, Li M, Zhang Y, de Barros SC, Rao DS, Counter CM, Chute JP. Sasine JP, et al. Among authors: counter cm. JCI Insight. 2018 Jun 7;3(11):e98197. doi: 10.1172/jci.insight.98197. eCollection 2018 Jun 7. JCI Insight. 2018. PMID: 29875320 Free PMC article.

10

Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid Cancer.

Xu M, Casio M, Range DE, Sosa JA, Counter CM. Xu M, et al. Among authors: counter cm. Clin Cancer Res. 2018 Sep 1;24(17):4271-4281. doi: 10.1158/1078-0432.CCR-17-3705. Epub 2018 Jul 31. Clin Cancer Res. 2018. PMID: 30065097 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page